This solicitation closed on July 9, 2026

View current NATIONAL INSTITUTES OF HEALTH opportunities →
ClosedGRANT

75N98026Q00716

NATIONAL INSTITUTES OF HEALTHHEALTH AND HUMAN SERVICES, DEPARTMENT OF.NATIONAL INSTITUTES OF HEALTH.NATIONAL INSTITUTES OF HEALTH OLAO

AI Overview

NCI research opportunity focused on corrective gene editing for splicing factor mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia. Addresses therapeutic development for hematologic malignancies.

This summary is AI-generated from the official solicitation.

Key Details

Agency
NATIONAL INSTITUTES OF HEALTH
Funding Amount
—
Release Date
June 30, 2026
Due Date
July 9, 2026 (Closed)

Official Description

NCI - Corrective Editing of Splicing Factor Mutant Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

View on official source

Change History

Opportunity AddedJun 30, 2026 at 5:03 PM

75N98026Q00716

New SAM.gov opportunity: 75N98026Q00716

Similar Opportunities

Forecast

Histopathology and antibody screening of Hutchinson Gilford progeria syndrome mouse model DNA editing therapeutic preclinical trial samples.

Due July 20, 2026

Active

N6449826Q5179

Due July 10, 2026

Forecast

Updates to NUREG-1520, NUREG-2212, and Related Interim Staff Guidance

Due July 13, 2026

Get Alerts for Opportunities Like This

RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.

Start Free Trial